Project
A Phase 3 Randomized, Double-Blind Study of NivolumabMonotherapy or NivolumabCombined with Ipilimumab vs Placebo in Participants with Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse
Completed · 2020 until 2024
Rothermundt Christian, Wittwer Yvonne, Quinter Janine
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2020
End Date
2024
Financing
Industry
Labels
kidney cancer